David E Gerber Selected Research

David E Gerber Research Topics

Disease

71	Neoplasms (Cancer) 03/2022 - 03/2006
51	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 12/2008
32	Lung Neoplasms (Lung Cancer) 03/2022 - 11/2009
11	Disease Progression 01/2022 - 12/2014
6	Pancreatic Neoplasms (Pancreatic Cancer) 07/2017 - 02/2008
4	Nausea 11/2022 - 12/2015
3	Diarrhea 11/2022 - 10/2017
3	Vomiting 11/2022 - 12/2015
3	Autoimmune Diseases (Autoimmune Disease) 09/2022 - 11/2016
3	Lymphoma (Lymphomas) 01/2022 - 05/2007
3	Neoplasm Metastasis (Metastasis) 07/2021 - 01/2019
3	Brain Neoplasms (Brain Tumor) 01/2021 - 05/2007
3	Exanthema (Rash) 01/2021 - 02/2008
3	Adenocarcinoma 11/2020 - 08/2013
3	Fatigue 01/2020 - 10/2017
3	Necrosis 10/2018 - 11/2015
3	Glioma (Gliomas) 04/2007 - 01/2007
2	Venous Thromboembolism 11/2022 - 08/2008
2	Carcinogenesis 01/2021 - 01/2017
2	Mouth Neoplasms (Oral Cancer) 01/2021 - 11/2019
2	Adenocarcinoma of Lung 10/2020 - 12/2015
2	Glioblastoma (Glioblastoma Multiforme) 12/2019 - 01/2007
2	Pneumonia (Pneumonitis) 01/2018 - 01/2017
2	Head and Neck Neoplasms (Head and Neck Cancer) 11/2015 - 03/2010
2	Hemorrhage 08/2014 - 08/2008
1	Cardiomyopathies (Cardiomyopathy) 11/2022
1	Febrile Neutropenia 11/2022
1	Tumor Lysis Syndrome 11/2022
1	Breakthrough Pain 11/2022
1	Spinal Cord Compression 11/2022
1	Hypercalcemia (Milk Alkali Syndrome) 11/2022
1	Mucositis 11/2022
1	Kidney Neoplasms (Kidney Cancer) 09/2022
1	COVID-19 01/2022

Drug/Important Bio-Agent (IBA)

20	Immune Checkpoint InhibitorsIBA 09/2022 - 01/2016
9	Pharmaceutical PreparationsIBA 12/2021 - 02/2008
8	NivolumabIBA 01/2022 - 10/2015
7	Tyrosine Kinase InhibitorsIBA 01/2022 - 08/2011
7	Biomarkers (Surrogate Marker)IBA 07/2021 - 11/2017
7	Monoclonal AntibodiesIBA 01/2015 - 04/2007
6	CytokinesIBA 03/2022 - 09/2010
6	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 08/2011
5	Biological ProductsIBA 07/2021 - 11/2011
5	PlatinumIBA 01/2021 - 03/2015
5	ErbB Receptors (EGF Receptor)IBA 03/2019 - 12/2008
5	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 09/2012
5	PhosphatidylserinesIBA 01/2016 - 08/2011
5	bavituximabIBA 01/2016 - 08/2011
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2010
4	Docetaxel (Taxotere)FDA Link 01/2021 - 10/2015
4	Bevacizumab (Avastin)FDA Link 11/2020 - 09/2012
4	beta-lapachoneIBA 10/2018 - 11/2015
4	Carboplatin (JM8)FDA LinkGeneric 02/2016 - 08/2013
4	Pemetrexed (MTA)FDA Link 03/2015 - 09/2012
3	brigatinibIBA 01/2022 - 02/2017
3	Circulating Tumor DNAIBA 01/2022 - 01/2021
3	AntibodiesIBA 01/2021 - 01/2019
3	VaccinesIBA 11/2020 - 05/2013
3	AntigensIBA 11/2020 - 04/2007
3	Anaplastic Lymphoma KinaseIBA 03/2019 - 12/2015
3	LigandsIBA 01/2019 - 10/2015
3	NAD (NADH)IBA 01/2019 - 11/2015
3	Etoposide (VP 16)FDA LinkGeneric 01/2017 - 07/2015
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017 - 11/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2013 - 09/2012
2	durvalumabIBA 01/2022 - 01/2020
2	IpilimumabIBA 01/2022 - 01/2017
2	Messenger RNA (mRNA)IBA 10/2020 - 01/2014
2	AutoantibodiesIBA 01/2020 - 01/2020
2	CTLA-4 AntigenIBA 01/2020 - 01/2019
2	Temozolomide (Temodar)FDA LinkGeneric 12/2019 - 01/2007
2	Adenosine Triphosphate (ATP)IBA 01/2019 - 11/2015
2	CatalaseIBA 01/2019 - 07/2017
2	ARQ 197IBA 01/2018 - 08/2011
2	Oxidoreductases (Dehydrogenase)IBA 07/2017 - 11/2015
2	quinone (benzoquinone)IBA 07/2017 - 11/2015
2	Phosphotransferases (Kinase)IBA 01/2017 - 01/2017
2	olaratumabIBA 01/2017 - 11/2012
2	CrizotinibIBA 12/2015 - 02/2015
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2015 - 06/2013
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2013 - 09/2012
1	Vasopressins (Vasopressin)IBA 11/2022
1	Thyroxine (Levothyroxine)FDA LinkGeneric 09/2022
1	Interleukin-8 (Interleukin 8)IBA 03/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2022
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 03/2022
1	alectinibIBA 01/2022
1	Thalidomide (Thalomid)FDA Link 12/2021
1	Etanercept (Enbrel)FDA Link 12/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021
1	Prednisone (Sone)FDA LinkGeneric 12/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	pembrolizumabIBA 01/2021

Therapy/Procedure

58	Therapeutics 03/2022 - 01/2007
26	Drug Therapy (Chemotherapy) 11/2022 - 02/2008
14	Immunotherapy 01/2021 - 05/2013
13	Radiotherapy 07/2021 - 01/2007
4	Maintenance Chemotherapy 01/2018 - 02/2011
2	Chemoradiotherapy 01/2022 - 11/2020
2	Precision Medicine 01/2017 - 12/2010